1 completed, 1 not yet recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Poly A: new trials by email Literature Review of Poly A trials Research Report on Poly A
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer Fluzoparib Capsules, Bevacizumab - Ovarian Cancer, High Grade Serous Adenocarcinoma of Ovary | Phase 2 | Not yet recruiting | Sun Yat-sen University | 44 | 2023-10-18 | 2023-10-02 |
| Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer Pamiparib, Surufatinib - Ovarian Cancer, Ovarian Carcinoma | Phase 1 / Phase 2 | Completed | Sun Yat-sen University | 29 | 2022-09-22 | 2026-03-10 |
Ovarian Neoplasms (2) · Fallopian Tube Neoplasms (1)
China (2)